This Viewpoint reviews early evidence of improved outcomes among patients with cancer and higher BMIs treated with tumor checkpoint inhibitors, and the scientific challenges of distinguishing the mechanism of favorable vs adverse effects of obesity on cancer epidemiology and responses to treatment.
Source: The Surprisingly Positive Association Between Obesity and Cancer Immunotherapy Efficacy